Onco Wiki / Maladie

Carcinome à cellules squameuses du pénis

Vue déterministe de l'entité source de la LJAM. L'autorité clinique demeure avec les ID de la source cités et l'état d'approbation de l ́examinateur.

IDDIS-PENILE-SCC
TypeMaladie
Alias
Cancer du pénisCSC pénile associé au VPHPénisCancer du pénisПлоскоклітинна карцинома пенісу
Étatreviewed 2026-05-18 | pending_clinical_signoff
MaladiesAucune déclaration
SourcesSRC-IARC-MONO-100B-2012 SRC-NCCN-BLADDER-2025

Informational support. All recommendations must be verified by a qualified oncologist. Engineering checks are not clinical validation or treatment approval.

Source YAML

icd_o_3_morphology8070/3
icd_o_3_topography["C60"]
icd_10C60
who_classificationWHO Urinary and Male Genital Tumours 5th ed (2022): Penile squamous cell carcinoma (HPV-associated + HPV-independent subtypes)

Capacités

Notes

Two biological subgroups (HPV-driven vs HPV-independent) managed similarly anatomically. Treatment: early-stage (Tis, Ta, T1a) — organ-sparing approaches (topical 5-FU / imiquimod for Tis; CO2- laser or wide local excision for T1a; glansectomy for selected T2); advanced primary (T2-T4) — partial / total penectomy; inguinal nodal management — dynamic sentinel node biopsy or modified inguinal lymphadenectomy per cN0 vs cN+ status (highly morbid, complications common); metastatic — cisplatin + 5-FU OR TIP (paclitaxel + ifosfamide + cisplatin) per EAU; pembrolizumab in MSI-H subset. HPV vaccination of boys (Gardasil-9) is the primary prevention modality alongside neonatal circumcision discussion.

Utilisé par

Algorithmes

Médicament

Indication

Signal d’alerte

Protocole thérapeutique

Sources